Dacarbazine and dyspnoea Patient Reports February 11, 2012

Dacarbazine Side Effects Report #4727558-7
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on July 27, 2005. Male patient, 42 years of age, weighting 136.7 lb, was diagnosed with respiratory distress and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: cough, dyspnoea, hypotension, infusion related reaction, oxygen saturation decreased, respiratory disorder, tachycardia, tachypnoea, wheezing. Dacarbazine dosage: 600 MG ONCE PR. During the same period patient was treated with GRANISETRON, BLEOMYCIN, DOXORUBICIN, VINBLASTINE, ZANTAC, LASIX, ROBITUSSIN. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #4620802-6
Dacarbazine side effect was reported by a Consumer or non-health professional from on Mar 14, 2005. Male patient, 72 years of age, weighting 133.5 lb, was diagnosed with metastases to lung, metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: anxiety , apnoea, cough, dyspnoea, heart rate increased, hypotension, productive cough, respiratory rate increased, throat tightness. Dacarbazine dosage: 1000 MG/M2, TOTAL DAILY, INTRAVENOUS. During the same period patient was treated with INTERLEUKIN, TELITHROMYCIN, CLARINEX D, GLUCOPHAGE, LOTREL, HYDROCHLOROTHIAZIDE, LIPITOR. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #4635250-2
Dacarbazine side effect was reported by a Consumer or non-health professional from on Mar 29, 2005. Male patient, 72 years of age, weighting 133.5 lb, was diagnosed with metastases to lung, metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: activities of daily living impaired, anxiety , blood pressure decreased, breath sounds decreased, cardio-respiratory arrest, cough, dyspnoea, heart rate increased, hypotension. Dacarbazine dosage: 1000 MG/M2, TOTAL DAILY, INTRAVENOUS. During the same period patient was treated with INTERLEUKIN, TELITHROMYCIN, CLARINEX, GLUCOPHAGE, LOTREL, HYDROCHLOROTHIAZIDE, LIPITOR. Patient was hospitalized. Patient died on 03/26/2005.

Dacarbazine Side Effects Report #5066534-4
Dacarbazine side effect was reported by a Physician from SWITZERLAND on July 20, 2006. Female patient, 79 years of age, weighting 191.8 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: abdominal pain lower, activities of daily living impaired, anxiety , dyspnoea, lower respiratory tract infection, metastases to bone, metastases to lung, productive cough. Dacarbazine dosage: unknown. During the same period patient was treated with BOSENTAN, PREDNISOLONE, ALPRAZOLAM, AMITRIPTYLINE, RANITIDINE, TEMAZEPAM, ENDONE, PRAVACHOL. Patient was hospitalized. Patient recovered.


Dacarbazine Side Effects Report #5069554-9
Dacarbazine side effect was reported by a Physician from SWITZERLAND on July 20, 2006. Female patient, 79 years of age, weighting 191.8 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: abdominal pain lower, activities of daily living impaired, anxiety , dyspnoea, lower respiratory tract infection, metastases to bone, metastases to lung, productive cough. Dacarbazine dosage: unknown. During the same period patient was treated with BOSENTAN, PREDNISOLONE, ALPRAZOLAM, AMITRIPTYLINE, RANITIDINE, TEMAZEPAM, ENDONE, PRAVACHOL. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5076113-0
Dacarbazine side effect was reported by a Physician from AUSTRALIA on July 26, 2006. Female patient, 78 years of age, weighting 191.8 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: abdominal pain lower, anxiety , bacillus infection, back pain , bacterial infection , cough, dyspnoea, lower respiratory tract infection, metastases to bone. Dacarbazine dosage: 850 MG/M2 IV. During the same period patient was treated with PREDNISOLONE, ALPRAZOLAM, AMITRIPTYLINE, RANITIDINE, TEMAZEPAM, ENDONE, PRAVACHOL. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5076249-4
Dacarbazine side effect was reported by a Consumer or non-health professional from AUSTRALIA on July 20, 2006. Female patient, 78 years of age, weighting 191.8 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: abdominal pain lower, activities of daily living impaired, anxiety , back pain , bacterial infection , cough, dyspnoea, lower respiratory tract infection, metastases to bone. Dacarbazine dosage: 850 MG/M2, INTRAVENOUS. During the same period patient was treated with BOSENTAN, PREDNISOLONE, ALPRAZOLAM, AMITRIPTYLINE, RANITIDINE, TEMAZEPAM, ENDONE, PRAVACHOL. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5584150-2
Dacarbazine side effect was reported by a Physician from UNITED KINGDOM on Dec 27, 2007. Female patient, 88 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: dyspnoea. Dacarbazine dosage: unknown. During the same period patient was treated with OXAZEPAM, ONDANSETRON. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5604209-0
Dacarbazine side effect was reported by a Physician from UNITED KINGDOM on Jan 22, 2008. Female patient, 88 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: dyspnoea, pulmonary embolism . Dacarbazine dosage: unknown. During the same period patient was treated with OXAZEPAM, ONDANSETRON. Patient was hospitalized. Patient recovered.


Dacarbazine Side Effects Report #5615253-1
Dacarbazine side effect was reported by a Physician from UNITED KINGDOM on Jan 30, 2008. Female patient, 88 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: dyspnoea, pulmonary embolism . Dacarbazine dosage: unknown. During the same period patient was treated with OXAZEPAM, ONDANSETRON. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #6079284-2
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2009. Male patient, 81 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, dyspnoea, metastatic malignant melanoma, myeloproliferative disorder, pneumonia primary atypical. Dacarbazine dosage: unknown. During the same period patient was treated with DASATINIB, LASIX, DARVOCET. Patient was hospitalized. Patient died on 01/20/2009.

Dacarbazine Side Effects Report #6100446-X
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 24, 2009. Male patient, 81 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, dyspnoea, metastatic malignant melanoma, myeloproliferative disorder, pneumonia primary atypical. Dacarbazine dosage: unknown. During the same period patient was treated with DASATINIB, LASIX, DARVOCET. Patient was hospitalized. Patient died on 01/20/2009.

Dacarbazine Side Effects Report #6062923-X
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 26, 2009. Male patient, 80 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, dyspnoea. Dacarbazine dosage: unknown. During the same period patient was treated with DASATINIB, LASIX, DARVOCET. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5339009-2
Dacarbazine side effect was reported by a Physician from NETHERLANDS on May 17, 2007. Female patient, 59 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: dyspnoea, haemoptysis. Dacarbazine dosage: unknown. Patient was hospitalized. Patient recovered.


Dacarbazine Side Effects Report #5746736-1
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on May 14, 2008. Male patient, 57 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, chest x-ray abnormal, dialysis , dyspnoea, glomerular filtration rate decreased, hepatorenal syndrome. Dacarbazine dosage: unknown. During the same period patient was treated with LEXAPRO, PAXENE, NAMENDA, CRESTOR, LISINOPRIL, TRAZODONE, KYTRIL. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5765307-4
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2008. Male patient, 57 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, dyspnoea, renal failure. Dacarbazine dosage: unknown. During the same period patient was treated with LEXAPRO, PAXENE, NAMENDA, CRESTOR, LISINOPRIL, TRAZODONE, KYTRIL. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5650785-1
Dacarbazine side effect was reported by a Physician from UNITED KINGDOM on Feb 28, 2008. Male patient, 49 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: dyspnoea, metastatic malignant melanoma. Dacarbazine dosage: unknown. During the same period patient was treated with TINZAPARIN, OXYCONTIN, ACETAMINOPHEN, LANSOPRAZOLE, CALOGEN, ENSURE PLUS, OXYNORM. Patient was hospitalized. Patient died on 01/04/2008.

Dacarbazine Side Effects Report #5806272-0
Dacarbazine side effect was reported by a Physician from UNITED KINGDOM on July 01, 2008. Male patient, 49 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: dyspnoea, metastatic malignant melanoma. Dacarbazine dosage: unknown. During the same period patient was treated with TINZAPARIN, OXYCONTIN, ACETAMINOPHEN, LANSOPRAZOLE, CALOGEN, ENSURE PLUS, OXYNORM. Patient was hospitalized. Patient died on 01/04/2008.

Dacarbazine Side Effects Report #4655833-3
Dacarbazine side effect was reported by a Health Professional from on May 06, 2005. Female patient, 39 years of age, weighting 116.0 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion. Dacarbazine dosage: 1600 MG IV. Patient was hospitalized. Patient recovered.


Dacarbazine Side Effects Report #5704411-3
Dacarbazine side effect was reported by a Physician from UNITED STATES on Apr 11, 2008. Male patient, weighting 142.2 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: anaphylactic reaction, dyspnoea, erythema, pleural effusion, skin lesion. Dacarbazine dosage: 1600MG, IV Q21DAYS. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5775231-9
Dacarbazine side effect was reported by a Physician from UNITED STATES on June 16, 2008. Male patient, weighting 126.8 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: anaemia, chronic obstructive pulmonary disease, condition aggravated, dyspnoea, pancytopenia. Dacarbazine dosage: 1600MG, IV Q21DAYS. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #6044418-2
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on Jan 15, 2009. Male patient, weighting 187.6 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, dyspnoea, fatigue. Dacarbazine dosage: 800MG/M2 Q3 WEEKS. During the same period patient was treated with DASATINIB, LASIX, DARVOCET. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #6077039-6
Dacarbazine side effect was reported by a Physician from UNITED STATES on Feb 11, 2009. Male patient, weighting 196.7 lb, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, nuclear magnetic resonance imaging brain abnormal. Dacarbazine dosage: 1050MG, Q21DAYS, IV. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient died on 02/04/2009.

Dacarbazine Side Effects Report #4766559-X
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on Aug 26, 2005. Female patient, 36 years of age, weighting 152.1 lb, was diagnosed with hodgkin's disease  and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: dyspnoea, pulmonary function test decreased, pulmonary toxicity. Dacarbazine dosage: unknown. During the same period patient was treated with NEULASTA, BLEOMYCIN SULPHATE, DOXORUBICIN HYDROCHLORIDE, VINBLASTINE SULPHATE, LORAZEPAM, PREDNISONE, DEXAMETHASONE. Patient recovered.


Dacarbazine Side Effects Report #4788963-6
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2005. Female patient, 36 years of age, weighting 152.1 lb, was diagnosed with hodgkin's disease  and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: dyspnoea, pulmonary function test decreased, pulmonary toxicity. Dacarbazine dosage: unknown. During the same period patient was treated with NEULASTA, BLEOMYCIN SULPHATE, DOXORUBICIN HYDROCHLORIDE, VINBLASTINE SULPHATE, LORAZEPAM, PREDNISONE, DEXAMETHASONE. Patient recovered.

Dacarbazine Side Effects Report #5712121-1
Dacarbazine side effect was reported by a Health Professional from JAPAN on Apr 07, 2008. Male patient, 35 years of age, was diagnosed with hodgkin's disease  and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: dyspnoea, pulmonary toxicity. Dacarbazine dosage: unknown. During the same period patient was treated with VINBLASTINE SULPHATE, BLEOMYCIN SULPHATE, DOXORUBICIN. Patient recovered.

Dacarbazine Side Effects Report #5247398-2
Dacarbazine side effect was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on Feb 22, 2007. Male patient, 17 years of age, was diagnosed with hodgkin's disease  and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: chills, cryptogenic organising pneumonia, dyspnoea, haemoptysis, pyrexia. Dacarbazine dosage: unknown. During the same period patient was treated with DOXORUBICIN, BLEOMYCIN, VINBLASTINE SULPHATE. Patient was hospitalized. Patient recovered.